Is Medicare drug coverage in jeopardy?
Republican committee leaders are pushing the Obama administration to call off proposed changes to the Medicare prescription drug program, arguing the overhaul would jeopardize seniors' plans and raise premiums. The charges pertain to recent regulations proposed by the Centers for Medicare and Medicaid Services (CMS). The rules would allow the agency to participate in negotiations between insurance companies and pharmacies in Medicare Part D for the first time out of concerns over cost and access. Supporters of the change argue the CMS needs new authority to ensure the market for prescription drugs in Part D works for patients.
- Transforming Decision Support and Reporting
- Providers Prep for New Payment Models as Population Health Grows
- Nurse Ethics Comes to a Head at Guantanamo Bay
- In Lakeport, CA, a Population Health Laboratory is Born
- CMS Mulls Income-Adjusting MA Stars
- 3 Ways to Rev Employee Development Programs
- Providers' Push to Consolidate Roils Payers
- As Retail Clinics Surge, Quality Metrics MIA
- Slideshow: Healthcare Executives Eye Efficiency
- No Employee Satisfaction, No Patient-Centered Culture